Press monitoring
Scientists completed the first orchid whole genome sequencing
28.11.2014 | Press monitoring
As one of the most diverse plant family, orchid now has its first genome sequenced and the result is published at Nature Genetics as a cover article. This study is an accomplishment of the Orchid Genome Project, an international collaboration led by Lai-Qiang Huang and Zhong-Jian Liu at Tsinghua University and National Orchid Conservation Center...
Researchers move ultrafast, low-cost DNA sequencing technology a step closer to reality
27.11.2014 | Press monitoring
A team of scientists from Arizona State University's Biodesign Institute and IBM's T.J. Watson Research Center have developed a prototype DNA reader that could make whole genome profiling an everyday practice in medicine. "Our goal is to put cheap, simple and powerful DNA and protein diagnostic devices into every single doctor's office,"...
Model evaluates where bioenergy crops grow best
26.11.2014 | Press monitoring
Researchers at the University of Illinois have published a study identifying yield zones for three major bioenergy crops. "The unique aspect of our study is that it provides detailed information about where these crops can grow, in terms of their location and stability over time, which has not been done in the past," said U. of I. atmospheric...
Enabling biocircuits: New device could make large biological circuits practical
25.11.2014 | Press monitoring
Researchers have made great progress in recent years in the design and creation of biological circuits -- systems that, like electronic circuits, can take a number of different inputs and deliver a particular kind of output. But while individual components of such biological circuits can have precise and predictable responses, those outcomes...
Bio-Inspired Bleeding Control
24.11.2014 | Press monitoring
Taking a cue from the human body’s own coagulation processes, researchers at UC Santa Barbara synthesize platelet-like nanoparticles that can do more than clot blood. Stanching the free flow of blood from an injury remains a holy grail of clinical medicine. Controlling blood flow is a primary concern and first line of defense for patients and...
Biochemists build largest synthetic molecular cage ever
21.11.2014 | Press monitoring
UCLA biochemists have created the largest-ever protein that self-assembles into a molecular "cage." The research could lead to synthetic vaccines that protect people from the flu, HIV and other diseases. At a size hundreds of times smaller than a human cell, it also could lead to new methods of delivering pharmaceuticals inside of cells, or to...
Bacteria become genomic tape recorders, recording chemical exposures in their DNA
20.11.2014 | Press monitoring
MIT engineers have transformed the genome of the bacterium E. coli into a long-term storage device for memory. They envision that this stable, erasable, and easy-to-retrieve memory will be well suited for applications such as sensors for environmental and medical monitoring. "You can store very long-term information," says Timothy Lu, an...
Chemistry trick may herald transformational next-generation RNAi therapeutics
19.11.2014 | Press monitoring
Small pieces of synthetic RNA trigger a RNA interference (RNAi) response that holds great therapeutic potential to treat a number of diseases, especially cancer and pandemic viruses. The problem is delivery—it is extremely difficult to get RNAi drugs inside the cells in which they are needed. To overcome this hurdle, researchers at University of...
Up to 80 million bacteria sealed with a kiss
18.11.2014 | Press monitoring
As many as 80 million bacteria are transferred during a 10 second kiss, according to research published in the open access journal Microbiome. The study also found that partners who kiss each other at least nine times a day share similar communities of oral bacteria. The ecosystem of more than 100 trillion microorganisms that live in our bodies...
Personalized cocktails vanquish resistant cancers
17.11.2014 | Press monitoring
Doctors may be able to overcome drug resistance in cancer by growing cells from a patient's own tumour and then blasting the cells with an array of compounds to see which ones work. A study published on 13 November in Science heralds this ultra-personalized future of cancer therapy. International efforts to sequence cancer genomes have yielded a...
